Friday, 23 Oct 2020

Bangla Version

COVAX to manufacture, distribute 2bn doses by 2021: WHO DG

No icon Pharmaceuticals

Health Desk- 10 Oct 2020: The aim of COVAX is to ensure that 2 billion doses are manufactured and distributed equitably by the end of 2021, said, Dr Tedros Adhanom Ghebreyesus.

Director-General of World Health Organization also said, ‘Once we have an effective vaccine, we must also use it effectively, and the best way to do that is by making sure it’s available to all countries equitably through the COVAX Facility.’

While addressing a media briefing on COVID-19 on Friday, the WHO chief said COVAX is an unprecedented partnership between WHO, Gavi, manufacturers and the Coalition for Epidemic Preparedness or CEPI, and has the largest portfolio of potential COVID-19 vaccines, with several in advanced human trials.

This week, China, the Republic of Korea and Nauru joined the COVAX Facility, bringing the total number of countries and economies that are part of the global initiative for vaccine access to 171, Dr Tedros added.

He said vaccines are one of the most powerful inventions in human history.